Articles from Antidepressants

Trazodone Not Associated With Reduced Risk for Dementia - Neurology Advisor

Trazodone Not Associated With Reduced Risk for Dementia  Neurology AdvisorTrazodone is not associated with a reduced risk for dementia compared with other antidepressants at the prodromal stage of disease.

Elderly people with depression are far less likely to be referred for therapy: study - Home Care Insight

Elderly people with depression are far less likely to be referred for therapy: study  Home Care InsightOlder adults are far more likely to be prescribed antidepressants than to be referred for psychological therapies to treat depression, according to new research.

SSRIs Interfere with Opioid Pain Relief - Rheumatology Advisor

SSRIs Interfere with Opioid Pain Relief  Rheumatology AdvisorResearchers at Stanford University conducted a study on SSRI antidepressants and prodrug opioids to see how they interact.

VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10 - GlobeNewswire

VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10  GlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company ...

Antidepressant Based on Ketamine Gets Backing From FDA Advisory Group - Technology Networks

Antidepressant Based on Ketamine Gets Backing From FDA Advisory Group  Technology NetworksA form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. At a 12 February meeting at the ...

Ketamine-like depression treatment on track for FDA approval - WPLG Local 10

Ketamine-like depression treatment on track for FDA approval  WPLG Local 10A ketamine-like drug for treatment-resistant depression was backed by a US Food and Drug Administration advisory committee on Tuesday. If it is then approved ...

Vulvodynia Treatment Market Projected to Register at 6.1%CAGR by 2028 - Press Release - Digital Journal

Vulvodynia Treatment Market Projected to Register at 6.1%CAGR by 2028 - Press Release  Digital JournalThere is an increasing tendency of women who have observed chronic vulvar pain once in a lifetime. If the pain is persistent for more than three months and has ...

Antidepressant based on party drug gets backing from FDA advisory group - Nature.com

Antidepressant based on party drug gets backing from FDA advisory group  Nature.comEsketamine could soon be approved for use in people, although questions remain about its efficacy and potential for abuse.

What You and Your Family Need to Know About Maternal Depression - The New York Times

What You and Your Family Need to Know About Maternal Depression  The New York TimesA government panel's new recommendations could bring hope to many women at risk for the condition. Here is what the group said and how you can use the ...

FDA Advisory Committee Recommends Approval of SPRAVATO(TM) (esketamine) Nasal Spray CIII for Adults - PharmiWeb.com

FDA Advisory Committee Recommends Approval of SPRAVATO(TM) (esketamine) Nasal Spray CIII for Adults  PharmiWeb.comTITUSVILLE, N.J., Feb. 12, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and ...

Pages